Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
CommuniVax Corner
- The team in Alabama plans to meet with their advisory board to develop strategies for promoting vaccination among people who have not decided whether to get their shots, or have elected to "wait and see."
- The team in San Diego has met with county leadership to provide report on findings from the community regarding vaccine uptake, with the goal of informing a county survey, and has also hosted a vaccine hesitancy forum.
- The team in Idaho presented initial findings at the Idaho Public Health Association Meetings in a PH-TED talk. This talk was also shown at the Idaho State University College of Arts and Letters Spring Celebration. Watch their presentation here.
- The team in Prince George's County, Maryland continues their work through the Health Advocates in Reach and Research (HAIR) program. Read more about their work here.
|
|
People, Perceptions, and Polls
|
|
VIDEO
Combatting COVID-19 Vaccine Hesitancy. A panel of BARDA experts came together to talk about the different yet significant ways they have contributed to developing medical countermeasures against COVID-19. Watch our discussion about the issues surrounding COVID-19 vaccine and treatment hesitancy -- and what it means to contribute to the pandemic response as members of one of the communities that have been disproportionately affected by this disease . (ASPR, 5/3/21)
|
|
NEWS
How to Sell the Coronavirus Vaccines to a Divided, Uneasy America. The question of whether to vaccinate sits at the center of America’s deepest sources of discontent: political hatred, racial injustice, institutional mistrust. And unlike a political campaign, which needs to persuade 50.1 percent of the voters, or a car commercial, which would be a smashing success if it captured 25 percent of consumers, this marketing blitz had to convince upward of 70 percent of the public — enough to reach herd immunity . (Washington Post Magazine, 4/26/21)
|
|
NEWS
Faith, Freedom, Fear: Rural America’s Covid Vaccine Skeptics. People say that politics isn’t the leading driver of their vaccine attitudes. The most common reason for their apprehension is fear — that the vaccine was developed in haste, that long-term side effects are unknown. Their decisions are also entangled in a web of views about bodily autonomy, science and authority, plus a powerful regional, somewhat romanticized self-image: We don’t like outsiders messing in our business . (4/30/21)
|
|
NEWS
The Hot-Person Vaccine. One vaccine in particular—from Pfizer—has somehow become the cool vaccine, as well as the vaccine for the rich and stylish. There has been some pushback on this narrative from Dolly Parton fans, who prefer the Moderna vaccine that she helped fund last year. Jon Ossoff, who is widely regarded online as the “hot senator,” has also made his own TikTok portraying all three of the vaccines available in the U.S. as equally cool and fun—a solid message in the interest of public health . (The Atlantic, 4/30/21)
|
|
TYPE
The Era of Mass Vaccinations is Ending. With more than half of Americans still unvaccinated, the COVID-19 immunization campaign is far from over. It is now entering a new phase. Instead of in convention centers and arenas, shots will be distributed across a larger number of smaller sites: pharmacies, doctors’ offices, churches, mosques, factory parking lots, barbershops, bars, breweries, even individual homes . (The Atlantic, 5/4/21)
See also:
|
|
RESEARCH
American Journal of Public Health. In its June 2021 issue, now available online, AJPH has featured a special collection of articles focusing on the role of COVID-19 vaccines in containing the disease and rebuilding confidence in public health . (AJPH, 6/21)
|
|
NEWS
Beer? Money? States and Cities Offer Incentives to Get Vaccinated. Scoring a dose of the coronavirus vaccine in America, once the equivalent of a winning lottery ticket, has started to resemble something else: a clearance sale. So much so that some states and cities, which are struggling to fill appointments as the demand for vaccine wanes, are turning to an array of not-so-subtle incentives to get shots into the arms of more Americans . (New York Times, 5/3/21)
See also:
|
|
Law, Policy, and Politics
|
|
NEWS
Victims of Rare Vaccine Injury Wait to See If U.S. Will Pay. A 2005 law -- extended last year to include the Covid-19 pandemic -- shields manufacturers and health-care providers from state and federal liability in instances of public health and bioterrorism emergencies. In exchange for immunity for vaccine makers, the federal government pledged compensation for adverse reactions to coronavirus treatments and vaccines, but it’s a program with a history of rejecting claims and a relatively high bar for recovering costs . (Bloomberg, 5/3/21)
|
|
VIDEO
The Challenge of Global Vaccine Equity. The funding and logistical arrangements for production and distribution of COVID vaccines made a year ago were based on politics rather than evidence -- "nationalism at its worst," said Rebecca Weintraub, MD, of Ariadne Labs and Harvard Medical School. "What we're seeing internationally," said CoVEReD co-host Harald Schmidt, PhD, "is the market playing out in a way that is not compatible with public good." Learn more about the University of Pennsylvania's COVID Vaccine Equity Research Dialogues (CoVEReD). (CoVEReD, 4/29/21)
|
|
Research, Development, and Clinical Practice
|
|
NEWS
Anxiety seems to be the culprit in J&J vaccine fainting spells. After conducting interviews with the 64 patients (out of 8,624) who displayed those symptoms at the five sites, the CDC concluded that none of the cases met their definition of serious side effects, and the majority were resolved within 15 minutes. The researchers attributed the symptoms to anxiety rather than any discrepancies between the J&J vaccine and its Pfizer and Moderna counterparts . (Vox, 5/1/21)
|
|
NEWS
Giving 2 Doses Of Different COVID-19 Vaccines Could Boost Immune Response. Basically, all vaccines work by showing people's immune systems something that looks like an invading virus but really isn't. If the real virus ever comes along, their immune systems will recognize it and be prepared to fight it off. Using two different vaccines is a bit like giving the immune system two pictures of the virus, maybe one face-on and one in profile. (NPR, 5/5/21)
See also:
|
|
NEWS
The Statistical Secrets of Covid-19 Vaccines. Confusion over the statistical measures of how well vaccines work, might be providing quiet (and mostly incorrect) justification for some people’s hesitancy. All that adds up to a delay in the widespread inoculation that will set the world back on course. Here’s to statistics—the cause of, and solution to, all of life’s problems. (Wired, 5/6/21)
|
|
WORKSHOP
COVID-19 Lessons to Inform Pandemic Influenza Response. This global public workshop will convene international experts, thought-leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response. The workshop will take place over May 18, May 21, and May 25. Registration is required . (National Academies of Medicine, 5/21)
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative and The Rockefeller Foundation.
|
|
|
|
|
|
|